key: cord-0850171-zqjcdyw4 authors: Atzori, Laura; Ferreli, Caterina; Mateeva, Valeria; Vassileva, Snejina; Rongioletti, Franco title: Clinico-pathologic features between different viral epidemic outbreaks involving the skin date: 2021-04-25 journal: Clin Dermatol DOI: 10.1016/j.clindermatol.2021.04.002 sha: febddd894a2cef92e36fbe39c811bbe17d2be750 doc_id: 850171 cord_uid: zqjcdyw4 The current COVID-19 pandemic has exceeded any epidemiologic prevision, but increasing information suggests some analogies with the major viral outbreaks in the last century, and a general warning has been issued on the possibility that co-infections can make the differential diagnosis and treatment difficult, especially in tropical countries. Some reports have pointed out that presence of high Dengue antibodies can give a false negative testing for SARS-CoV-2. Muco-cutaneous manifestations are very frequent, with an apparent overlap among different pathogens. However, strong clinico-pathologic correlation might provide some clues to address differential. Waiting for laboratory and instrumental results, the timing and distribution of skin lesions is often pathognomonic. Histopathologic findings characterize certain reaction pattern, and provide insights on pathogenetic mechanisms. Unfortunately, skin assessment takes a back seat in severely ill patients, especially invasive exam such as biopsy. A literature retrieval was performed to collect from other epidemics as much information to counteract what has become the most frightening disease of our time. According to the World Health Organization (WHO), viral diseases continue to emerge as a serious issue to public health. Examples of the impact of globalization on infective disease epidemiology are abundant, from the New World colonization and spread of smallpox virus and syphilis to the influenza virus pandemics following the great War. 1 However, what is stirring the medical community concern is the explosive spread of novel diseases in the new millennium, which of course depends on the huge implementation of human travel and transport, but is causing a collapse of public health systems worldwide. Chikungunya begun circulating in South America. 2 Medicine is trying to evolve and find solution just as quickly, protecting populations lacking native immunity with effective vaccination campaigns. 3 An example is Yellow fever containment in South America, preventing large-scale circulation in the United States. 4 However, current 2019 novel coronavirus (SARS-CoV-2) pandemic has completely upset any epidemiological prevision, 4-9 as covid-19 caused an unexpectedly high rate of mortality and morbidity reminiscent of the great influenza pandemic. The skin is frequently affected in all viral epidemics, [9] [10] [11] and recognitions of mucocutaneous manifestations might contribute to the early diagnosis or even provide prognostic significance, pointing out the disease phases. Main limitation is that skin manifestations are rather polymorphous and aspecific, and strong epidemiologic, clinical and pathologic correlation is necessary to address the differential diagnosis. Moreover, histopathologic characterization is often insufficient due to the reluctance to perform invasive examinations in severely ill patients, or because dermatopathology services are not easily available in emergency settings, especially in the developing countries. Although expensive and time-consuming, refined immunohistochemical examination usually provide powerful insights on pathogenesis, 10 helping to distinguish the direct cytopathic effects of the pathogen from the host exaggerate immune response, or other concomitant conditions exacerbating the final tissue damage. The aim of this review is to provide an overview of muco-cutaneous manifestations of the major epidemic viral infections (Tab. 1), with a special emphasis on clinico-pathologic correlation, and comparison with SARS-CoV-2. Over the past two decades, 3 zoonotic coronavirus outbreaks have occurred: 1. SARS starting in 2002 in China due to SARS-CoV; 2. MERS starting in 2012 in Saudi Arabia due to MERS-CoV; 3. Covid-19 due to SARS-CoV-2 starting in 2019 in Wuhan, China resulting in an ongoing pandemic. [12] [13] [14] [15] [16] Phylogenetic analysis confirms strong homologies among coronavirus, [17] [18] [19] as well as respiratory symptoms and pathologic findings, supporting a similar cytokine cascade storm as responsible of the patient rapid death. [20] [21] [22] However, SARS-CoV-2 has spread in the community more easily, exceeding 1 million cumulative death at the end of September 2020 following WHO data. 23 Behind the total dramatic numbers, the mortality rate (2.3%) is lower than SARS (9.5%) and much lower than that of MERS (34.4%). SARS-CoV-2 in most patients cause mild or asymptomatic disease, which is probably favoring circulation of the virus. [12] [13] [14] [15] [16] The basic reproductive number (R0), although variable among geographical areas, is currently attested around 2.0-2.5, slightly higher than SARS (1.7-1.9) and higher than that of MERS (<1). Social containment, with quarantine of suspected cases and contacts, strict physical distancing and hygiene measures are crucial to effectively reduce R0 and associated mortality. 4 From a dermatology stand-point, the most relevant difference between COVID-19 and SARS/MERS is the absence of reported skin manifestations in the latter, while COVID-19 is associated with an increasing list of skin eruptions. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] One explanation for the apparent different skin tropism of the novel coronavirus is that the greater severity of lung and multiorgan involvement in SARS and MERS, with a relatively fast course, has deserved less attention to skin signs. 15 Another consideration is worth the number of infected, which has exceed the 32 million (WHO), 23 thus allowing the observation of relatively rare events. In COVID-19, the prevalence of skin involvement ranges from 0.2% in a cohort of Chinese patients 25 to 20.4% in an Italian study. 26 A systematic review indicates a worldwide incidence of 1-2%. 24 According to the Spanish prospective nationwide consensus study, 27 the most characteristic presentations are chilblain-like lesions, ischemic-livedoid/necrotic lesions and varicelliform-like/vesicular eruption. More frequent, albeit less specific manifestations are the erythematous, urticarial, purpuric and maculopapular eruptions, followed by an increasing list of anecdotal and unusual manifestations. [28] [29] [30] [31] [32] [33] [34] Recently, a peculiar Kawasaki-like presentation during the COVID-19 pandemic has been described, 35, 36 and named multisystem inflammatory syndrome (MIS) with a 30-fold increased rate in Italian children. 37 Chilblain-like lesions consist of erythematous-violaceous papules and macules with purpuric hue and possible vesicles, bullous, pustules on acral area, especially on toes. 24, 27, [38] [39] [40] They affected young people, in such a high percentage never reported before the outbreak of COVID-19. Distribution is usually asymmetrical and lesions may be asymptomatic, itching or painful. Histopathology shows a superficial and deep perivascular lymphocytic infiltrate with signs of endothelial activation. [41] [42] [43] Angiotensin-converting enzyme 2 (ACE-2), the receptor for SARS-CoV-2 spike protein, is expressed in the dermal endothelial cells, as well as in the keratinocytes of epidermal basal layer and eccrine glands in chilblain-like lesions. 43, 44 Although highly suspect, several patients with chilblainlike lesions resulted negative for SARS-CoV-2 polymerase chain reaction and serology and the presence of the virus might be explained with a limited involvement of the adaptative immunity in young patients with asymptomatic or mild disease. [46] [47] [48] [49] In any case, the occurrence of chilblain-like lesions represents a potentially alerting sign of asymptomatic carriers in a risky population, and address the strict adoption of preventive social containment measures. The second type of lesions, characterized by an ischemic/livedoid necrotic skin is associated with severe illness, with microscopic findings including occlusive vasculopathy, extravasation of erythrocytes and fibrin thrombi in the vessels, similar to the pathological abnormalities of affected internal organs. 21, 27, [50] [51] [52] [53] [54] Blood exams usually confirm a hypercoagulability state. [55] [56] [57] Advanced age, together with comorbidities, unleashes an exaggerate innate immune response, named macrophage activation syndrome associated with a more severe prognosis. 10, 21, 24 Direct immunofluorescence on skin samples has outlined the presence of IgA-and complement in the vessel walls, which might be a key factor of the vasculopathic process. 58 By converse, the varicella-like/vesicular eruption is usually associated with symptomatic disease, occurring 3 days after fever, and respiratory symptoms in 9 to 18% of patients, but without a clear prognostic significance, as patients might both recover or underwent a more unfavorable course. 10, 21, 32, 59 In the Italian experience, 13.6% of these patients died of COVID-19. 32 Viral cytopathic effects have been documented in early skin biopsies, and interaction with the ACE-2 seems able to induce acantholysis and dyskeratosis. 32, [59] [60] [61] More skin biopsies and immunohistochemical staining with antibodies to SARS-CoV/SARS-CoV-2 spike protein on paraffin-embedded specimens and RNA detection of SARS-CoV-2 strain by real-time PCR-based assay will improve our capacity to distinguish co-incidence from casual correlation to COVID-19, 62-64 especially in patients whose nasopharyngeal swab and serologic tests resulted negative High mortality rate and contagiousness of coronavirus outbreak in the new millennium, related to inter-human air-born transmission and respiratory illness, remind us of what happened at the beginning of the last century. The 1918 influenza A virus, subtype H1N1, of the Orthomyxoviridae family, still represents an enigma. 65 The influenza rapid global spread is only partially explicable with the massive movement of people, and poor general conditions associated with the great war, as the virus was circulating in most part of the world many months before the spreading of the lethal form in late 1918. [66] [67] [68] A first wave of infections is documented from march to June, while the second highly lethal wave started from august 1918, supporting two separate but interrelated influenza pandemics in a single year. Despite several hypothesis, there is no final explanation for how the virus could suddenly increase its lethality worldwide. 62 The other troublesome novelty was the high young mortality rate, the decades from 20 to 40 years much affected that expected. 69 Particularly, in most populations, an infection peak decimates the 1890 birth cohort, vulnerable to a worse outcome. In that specific year, the H3N8 influenza pandemic had occurred, giving place to the hypothesis that early life influenza exposure in 1890 might have enhanced mortality at following adulthood H1N1 infection. 70 One explanation of such enhanced disease, called "original antigenic sin" is that subsequent serological reaction through non-neutralizing antibodies increases the virus's ability to infect the respiratory epithelial cells. The consequence seems that immunization is not always advantageous to the host. In line with such alarming hypothesis, observational Canadian studies report that seasonal influenza immunization increased illness during the 2009 influenza pandemic. 68 Two muco-cutaneous signs characterized this pandemic influenza, differing from every other influenza epidemic before and after: nose bleeding and cyanosis. [69] [70] [71] [72] [73] [74] The hemorrhagic phenomenon, although severe, was mainly confined to epistaxis, as frank hemoptysis was rare, as well as other bleedings, except for an increased menometrorrhagia in women. The other distinctive sign was skin discoloration, described as a diffuse dark blue cyanosis, and named "heliotrope cyanosis". 75 Occurrence of such remarkable discoloration had prognostic significance, as 95% of soldiers presenting such cyanosis usually died within a single day. 76 Patients appeared conscious to nearly the point of death. Histo-pathology examination pointed out that both manifestations are related to the massive destruction of the respiratory epithelium, with cellular necrosis. 77 The loss of respiratory epithelial cells was responsible of an initial acute tracheo-bronchitis, extending to the lung parenchyma and allowing the entry of bacteria, especially common pyogenic pathogens. 76 Fatal outcome was related to the entire lung failure, with oxygen saturation abruptly falling down, the alveoli filled with fluid. 77 Being a pre-antibiotic era, the secondary bacterial pneumonia resulted in the death of approximately one third of the influenza patients. An important lesson from 1918 influenza pandemic is the crucial role of preventive measures strategies to contain spreading: isolation of symptomatic patients appeared as the best weapon to minimize their exposure to other persons, and prevent acquired bacteria secondary infections. 66 Hospital's admittance emerged as a not efficacious measure, the wards being full of sick patients, increasing the exposure to many respiratory pathogens besides influenza virus. The lack of effective treatment was of course a pivotal factor for fatal outcomes at that time, but people managed at home showed a better prognosis than those referred to hospitals. 66 Nowadays, the extensive use of antibiotics in intensive care units as well as in the general population expose us to an equally or even higher risk of bacterial superinfections, as currently experienced during COVID-19 pandemic. We can find analogies to current reluctance to admit mild symptomatic patients into hospitals, and implementation of home-based assistance to contrast COVID-19 circulation. The sudden passing of the 1918 pandemic is another difficult to explain fact about the most lethal influenza virus ever recorded, which hopefully would also happen with COVID-19 pandemic. Last decades epidemics have been characterized by emergence of arbovirus, especially Dengue, Zika, and Chikungunya virus. The skin is a major portal of entry for such pathogens, being transmitted through mosquitos' bites, mainly of the Aedes family. 75 The most competent mosquito is Aedes aegypti, commonly called the yellow fever mosquito, which is an African insect reaching the Americas at the time of the slave trade, hidden in the ships. The other prevalent vector is the Asian tiger mosquito (Aedes albopictus), more recently circulating also in southern United States, and Europe, coming from Asia by way of egg-laden water amid shipments of the most disparate goods, including used tires. Stating the role of human activities, transports, and travel exchanges, cyclic epidemics spread from endemic areas, between the Pacific and Atlantic oceans. Co-infections is an increasing problem, all three-arbovirus spreading in the inter-tropical countries, and actual COVID-19 pandemic envisages the increasing danger of a very difficult differential, already signaled with dengue fever. [79] [80] [81] Symptoms are widely overlapping: fever, myalgia, headache, arthralgia and thrombocytopenia. Muco-cutaneous manifestations, with a hemorrhagic hue are common, but in respect to other viral exanthema, they occur characteristically late after constitutional symptoms, and are not obligatory signal of progression to authentic hemorrhagic disease or shock. However, individual predisposing conditions, especially microangiopathic diathesis might favor bleeding and life-threatening complications, requiring inpatient management. [82] [83] [84] Another crucial increasing phenomenon is vertical transmission from pregnant woman, causing neurologic symptoms and malformations, including microcephalia, seizure and/or encephalopathy. 85 As the symptomatology is common to any of the three arboviruses, in most cases only serological tests can differentiate one infection from another. However, some skin findings are useful to steer the diagnosis in experienced physicians. During the last half of the 20th century, dengue has spread to most countries in the tropical zones becoming the most common cause of human arbovirus infection, especially during the rainy season at the beginning of each year. 86 This RNA virus belongs to the genus flavivirus. The infection is most often asymptomatic, with some patients developing arthralgia, thrombocytopenia and episodes of vascular extravasation, which, if not adequately managed, can progress to severe forms. Dengue may be associated with neurological and hematological complications, including severe secondary thrombotic thrombocytopenic purpura (TTP). 84, [85] [86] [87] [88] [89] A predisposing microangiopathic diathesis is supposed to favor platelet hyper aggregation and formation of microthrombi in the endothelium. 82 However, viral infections including Dengue are well-known inducers of inhibitor autoantibodies production, directed against the proteinase ADAMTS13, deputy to the von Willebrand factor (vWF) multimer cleavage. A severe deficiency of the ADAMTS 13 protein (defined as activity below 10%), compromises substantially the coagulation and platelet aggregation pathway. 82 As regards skin manifestations, a generalized skin rash is described in 50 to 82% of patients, 90 and can be helpful to suggest the diagnosis in very early phase of the infection in endemic regions. First sign is the occurrence of a facial, neck and trunk flushing, within 24-48 hours from general symptoms onset, followed by the widespread eruption on day 3-6. Itching is reported in minority of patients, favoring differential with Zika, which is highly pruritic. 91, 92 Morphology is variable, predominantly morbilliform but also maculo-papular or petechial. White islands of sparing "in a sea of red" are described as a very pathognomonic sign. Mucosal involvement is described in 15-30% of cases, 86 especially of the conjunctiva and oral mucosa. 90, 93, 94 During the generalized eruption, the face is usually spared, and initial flashing has been explained with a temporary capillary's dilatation. Pruritic palm and soles swelling has been reported as a better prognostic sign, while hemorrhagic manifestations and genital involvement are associated with a higher rate of platelet infusions. 94 Skin necrosis and digital gangrene has been reported in patients with thrombotic thrombocytopenic purpura. 82 Histopathology is seldom performed, as is rather aspecific, showing a mild perivascular infiltrate of lymphocytes in the superficial dermis, exocytosis and variable red cell extravasation, particularly in the hemorrhagic form of the disease. 95 An immunohistochemistry study using CD1a-positive Langerhans cells double-labeled with an antibody against DV envelope glycoprotein, from cadaveric skin explants, than confirmed by a skin rash biopsy from a vaccinated patient suggest that skin Langerhans cells are preferential target of DENGV, being 10-fold more permissive than blood monocytes, and probably involved in the transmission via the lymphatics, after the mosquito bite. 96 The histopathological findings are of no prognostic value in predicting the course of the disease. 97 A general alert has been diffused for the overlapping signs and symptoms with COVID-19, especially the petechial rash, making differential diagnosis with Dengue and treatment difficult. 79 From the first case reported in Thailand, 80 an increasing reporting has pointed out that presence of high Dengue antibodies can give false negative testing for SARS-CoV-2. In this setting, only reverse transcription polymerase chain reaction (RT-PCR) testing is resolutive. 81 The human disease was firstly described in Africa in 1952-1953, 98 100 but an emerging occurrence of potentially severe immunological phenomena have been described, including encephalitis, Guillain-Barré syndrome, immune-mediated thrombocytopenia, and congenital nervous system malformations from vertical transmission in pregnant woman. [101] [102] [103] [104] Perinatal infection is also reported in endemic areas, such as India, and Colombia. [102] [103] [104] [105] Almost rarely, in respect to Dengue, the occurrence of secondary thrombotic thrombocytopenic purpura has been reported, leading hemolytic anemia, bleeding complications and renal failure. 98, 101 Chikungunya distinctive features beyond aspecific fever, headaches and general malaise are prominent joint-related symptoms, and peculiar dermatologic manifestations. 106-115 A maculopapular eruption occurs in about 1/3 of patients, 106 3-5 days after general symptoms onset, but a more pathognomonic sign is the facial melanosis, especially the nose pigmentation, which might support retrospective diagnosis of chikungunya fever. 102, 108-110 Acral edema, intertriginous hyperpigmentation and aphthae-like lesions, purpuric lesions accentuated in photo exposed areas are other quite striking findings. A vesiclebullous eruption, becoming hemorrhagic, and ulcers in most severe cases has also been reported. 111, 112 Bullous lesions and hyperpigmentation over the axilla, perioral and genital areas were reported in infants from India. 103 Atypical muco-cutaneous manifestations, with ulcers occurrence in the scalp, abdomen, genital and perianal region were report in newborn and infants in Colombia. 105 Nail pigmentations (red lunula, melanonychia), 115 and eczematous changes over preexisting scars, resembling sarcoidosis scar phenomenon have been reported. 102 Exacerbation of psoriasis or an eruption resembling guttate psoriasis in patients without previous history of psoriasis has also been described. 109 Skin biopsy is rarely performed, and histopathological findings of the skin rash is aspecific, showing features commonly seen in viral exanthems: a mild superficial perivascular infiltrate of lymphocytes, and occasional focal lichenoid reaction. 106 Vesicle-bullous lesions have been described both as intraepidermal and subepidermal detachment. 108 A characteristic finding is an increased basal pigmentation, with pigmentary incontinence, and melanophages. 102 Psoriasis-like lesions are superimposable to true psoriasis, although more dermal edema and melanophages are reported. 102 The skin is the first human organ to harbor the infection after the mosquito bite, and dermal fibroblasts constitute the main site of CHIKV replication, and amplification, as demonstrating in vitro, in animal models and in a skin biopsy from a fatal neonate case. 116 Along with dermal fibroblasts, keratinocytes, and melanocytes are also permissive for CHIKV, explaining the prevalence of hyperpigmented lesions. The infection induces a strong antiviral interferon-type-I (IFN-I) response, and pro-inflammatory cytokines release, but components of the Aedes mosquito saliva seems to contrast it, favoring viral replication. The route from the skin to viremia and other organs involvement pass through draining lymph nodes, and infected monocyte-derived-macrophages. During the viremia, dissemination of the virus back into the skin results in epidermal, dermal and capillary endothelial injury, due to a combination of direct cytopathic effect and immunological factors. Diagnosis is based on serology (anti-CHIKV IgM), and reverse transcription-polymerase chain reaction (RT-PCR) confirmation. The CHIKV tends to resolve spontaneously and almost symptomatic treatment is provided. However, effective administration of intravenous immunoglobulin therapy has been reported in a severe Brazilian patient, 111 while severe TTP occurrence beneficiate of plasmapheresis. 82, 117 Zika virus (ZIKV) belongs to the flavivirus, evoking general attention because has progressively moved from Africa and Asia, to the Americas, and Europe, causing limited epidemics, but with increasing pathogenicity. 78 extending surveillance for ZIKV also to European Union. 118 The possible person-to-person transmission through sexual intercourses was also pointed out, although accounting for only 1% of cases. [119] [120] [121] [122] Self-limitation of the epidemics is related to the type of mosquito species in the area, thus confining the disease to residents and occasional travelers. In fact, Aedes albopictus, which is the prevailing mosquito in Europe seems not to be an efficient vector, and no autochthonous cases have been detected in the surveillance European program from 2015 to 2017. 118 Incubation from mosquitos' bite inoculation ranges between 3 and 10 days. Skin manifestations are considered a valuable hallmark of the disease, because although the rash is by itself aspecific, characteristically occurs 24-48 hours after the onset of the general flu-like symptoms. [123] [124] [125] [126] This very short time lapse is the clue to differentiate Zika from other exanthematous diseases frequent in the same geographical areas, including dengue, and Chikungunya, whose rash manifests 4-5 days after the symptoms' onset. Morphology is variable, mainly maculopapular, but also arranged in linear net-shaped pattern, or even wheals, bleaching on palpation. Intensity and distribution of the erythema is variable, but is usually wide spread and symmetric, also affecting the face, and palms and soles. A distinctive pattern with erythema accentuation on neckline, radix of limbs and abdomen has been reported, as well as erythroderma. 126 Diagnosis is confirmed through nucleic acid testing (NAT) of whole blood, serum or urine. Ebolavirus, together with Marburgvirus belong to the Filoviridae family, order Mononegaviruses, characterized by single-stranded RNA genomes of negative polarity, and an elongated filamentous morphology at electron microscopy. 127 They are closely related to measles (Paramyxoviridae) and rabies. Ebolavirus is subdivided into five species: Zaire, Cote d'Ivoire, Sudan, Reston and Bundibugyo (recently discovered in Uganda), and classified as level 4 pathogens, among the most virulent and hazardous agents. EBOV causes outbreaks of fulminant hemorrhagic fever, mostly in equatorial Africa, with a mortality rate of up to 90%. [128] [129] [130] Main reservoir and infection source are fruit bats, 131 but human infection might also occur through contact with body fluids of infected large-animal carcasses or other humans, by accidental transmission during medical care, or burial practices. The disease occurs after a very variable incubation, from 1 to 21 days and onset is rather aspecific, with abrupt flu-like symptoms. Epidemiological information is crucial to address presumptive diagnosis and detect circulating viral antigens, although genetic identification in material by polymerase chain reaction (PCR) is not available in all laboratories. The second phase of the disease is characterized by multiorgan involvement and evolution into the third terminal phase is widely conditioned by host factors, death usually occurring after 2-3 day, while survivors experience a long prostrating convalescence. There is no specific treatment or vaccine, and treatment is solely supportive. Isolation measures and aseptic burial are crucial. Skin manifestations are not specific, 127 but absence of pruritus is a clue to differentiate the maculo-papular eruption from other viral exanthema, endemic in the same areas, such as ZIKA. Moreover, timing is characteristic, the rash occurring 4-6 days from symptoms onset, and alerting on the phase 2 disease transition. Patients have "ghost-like" features, and the rash, more evident in light-skinned patients, often evolve in a centripetal fashion, from upper arms to flexor forearms, and upper legs. 132 Mucosal involvement is also common, with a bilateral conjunctivitis in about 50% of patients, sore-like mouth lesions, gingivitis, glossitis and pharynx inflammation. Enanthem on the soft palate can help presumptive diagnosis, for the presence of small whitish dots on the dry erythematous mucosa, resembling "tapioca granules". All mucosal lesions can bleed, alerting on more hemorrhagic manifestation's onset. 132 Around day 8 the entire body is usually diffusely erythematous, with a dark livid huge, sometimes accompanied by true cyanosis. 127 Survivors experience affected skin peeling, especially on palms and soles, lasting from few days to weeks. Hair loss is also common after convalescence. Skin biopsy are seldom performed because of to the invasiveness of the exam in severely ill patients, and time-consuming results, equipped pathology services not usually available in the outbreak areas. 127 However, formalin-embedded samples are not contagious, and can be sent to specialized laboratories abroad. The few skin histopathologic reports suggest non-specific findings, 132 showing a mainly perivascular superficial and deep perivascular infiltrate, with vessels swelling. Alterations are mainly restricted to endothelial cells, dermal fibroblasts, and extracellular matrix around sweat glands. 133 Necrosis is also a common finding. Immunohistochemistry provides more information, showing EBOV antigen wide-spread distribution within dermal endothelial cells and fibroblasts, around and within sweat glands, while more scattered on epidermis. 135 Electron microscopy confirms viral inclusions within the cytoplasm of endothelial cells, fibroblasts, and extracellular matrix. 132, 135 As consequence of the COVID-19 emergency, medical community has been committed in a race against time to provide containment measures as well as management, in the wait for effective treatments. Lessons from previous epidemics are valuable source of information. 1,136 Skin involvement is common in any viral infections, [9] [10] [11] 78 and considering the general alert on the possible co-infection's occurrence, especially in tropical countries, [79] [80] [81] indication of clinical, and histopathologic clues to address differential is paramount. A first lesson coming from the only comparable pandemics, the 1918 influenza, is the importance of case identification and isolation, patients managed at home showing a better prognosis than those referred to hospitals. 65 Of course, the severe pneumonia and acute respiratory distress syndrome (ARDS), require intensive care assistance, but preventive measures are paramount to stop circulation of the virus, which is less lethal, but more contagious than previous coronavirus epidemics. [13] [14] [15] [16] Another alert from the influenza experience is the progressive involvement of younger patients, with concern about the role of previous not protective immunization and exaggerate immune response. However, effective treatment experimentation is ongoing as well as fast development of different vaccines for COVID-19. An increasing reporting of SARS-CoV-2 associated muco-cutaneous manifestations has highlighted the analogies with arbovirus, and Ebola findings. Strong clinico-pathologic correlation might provide clues to address differential. Timing and distribution of skin lesions is often pathognomonic, in the wait for laboratory and instrumental results. Unfortunately, histopathologic sampling is seldom performed, but retrieval of the few reports from the literature provide insights on repetitive pathogenetic mechanisms. Dermatologists are in the best position to identify minimal clinico-pathologic signs helpful in the early recognition of viral exanthema, and address presumptive differential in the wait for laboratory and instrumental results. Post-graduate education and strict cooperation with multidisciplinary infective diseases team is paramount to enrich both dermatological and general medical community expertise to counteract current COVID-19 pandemic, whose abrupt lethal potential has inexplicably burst as influenza pandemic in 1918, and hopefully will implode just as quickly and definitely. What can we learn from previous pandemics to reduce the frequency of emerging infectious diseases like COVID-19? Emergent diseases in emergent countries: we must study viral ecology to prevent new epidemics Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 -11 COVID-19) pandemic: increased transmission in the EU/EEA and the UKsixth update 2020 Viral exanthems Lessons from dermatology about inflammatory responses in Covid-19 Contemporary infectious exanthems: an update The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? COVID-19, SARS and MERS: are they closely related? The novel zoonotic COVID-19 pandemic: An expected global health concern Mers-CoV and COVID-19: what differences from a dermatological viewpoint? Insight into 2019 novel coronavirus -An updated interim review and lessons from SARS-CoV and MERS-CoV Emerging coronaviruses: Genome structure, replication, and pathogenesis The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Pathological findings of COVID-19 associated with acute respiratory distress syndrome A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis World Health Orgaization, Weekly Epidemiological Update Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature Clinical characteristics of coronavirus disease 2019 in China Cutaneous manifestations in COVID-19: a first perspective Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases COVID-19 and cutaneous manifestations: A systematic review The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries Cutaneous signs in COVID-19 patients: A review Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review Hyperinflammatory shock in children during COVID-19 pandemic Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Acral cutaneous lesions in the time of COVID-19 Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection Histologic features of long-lasting chilblain-like lesions in a pediatric COVID-19 patient COVID-19) infection-induced chilblains: A case report with histopathologic findings Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient Acro-ischemia in hospitalized COVID-19 patients Late onset of acral necrosis after SARS-CoV-2 infection resolution Acral ischaemia with multiple microthromboses and imminent gangrene in a 73-year-old woman with COVID-19 A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19 Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia Introductory histopathological findings may shed light on COVID-19 paediatric hyperinflammatory shock syndrome Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudo herpetic Grover disease seems to appear in patients with COVID-19 infection Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not 'varicella-like High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2 SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient Insights from unusual aspects of the 1918 influenza pandemic Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918e20 pandemic: a quantitative analysis Dating the emergence of pandemic influenza viruses Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus Pathogenic responses among young adults during the 1918 influenza pandemic Re-examining the evidence regarding circulation of a human H1 influenza virus immediately prior to the 1918 Spanish Flu Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada Clinical manifestations of pandemic (H1N1) 2009 in the ambulatory setting Observations on influenza and its complications Influenzo-pneumococcal and influenzostreptococcal septicaemia: epidemic influenzal pneumonia of highly fatal type and its relation to purulent bronchitis History of the Great War based on official documents The pathology of influenza virus infections Pandemic influenza and secondary pneumonia at camp Fremont, Calif Zika and Chikungunya: Emerging Arboviruses in the New World Coinfection, coepidemics of COVID-19, and dengue in dengueendemic countries: A serious health concern COVID-19 can present with a rash and be mistaken for dengue Diagnosis of COVID-19 in a Dengue-Endemic Area Thrombotic thrombocytopenic purpura associated with dengue and chikungunya virus coinfection: case report during an epidemic period Fatal case of Chikungunya and concomitant thrombotic thrombocytopenic purpura in French Guiana during air flight medical evacuation Dengue virus infection triggering thrombotic thrombocytopenic purpura in pregnancy Manifestações neurológicas de dengue: estudo de 41 casos Diagnosis and management of dengue Dengue and aplastic anemia: a rare association A dengue infection without bleeding manifestation in an adult with immune thrombocytopenic purpura Clinical features of 62 imported cases of dengue fever in Japan Cutaneous manifestations in patients of dengue fever Mucocutaneous manifestations of dengue fever Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis Dermatological manifestations of dengue fever Clinical significance of skin rash in dengue fever: A focus on discomfort, complications, and disease outcome A florid skin rash in a returning traveller Human skin Langerhans cells are targets of dengue virus infection Skin histopathology and immunopathology are not of prognostic value in dengue haemorrhagic fever Systemic infections mimicking thrombotic thrombocytopenic purpura Infection with chikungunya virus in Italy: An outbreak in a temperate region Prevalence of asymptomatic Zika virus infection: A systematic review Fatal case of Chikungunya and concomitant thrombotic thrombocytopenic purpura in French Guiana during air flight medical evacuation Cutaneous Manifestations of Chikungunya Fever: Observations from an Outbreak at a Tertiary Care Hospital in Southeast Rajasthan Atypical mucocutaneous manifestations in neonates and infants with chikungunya fever in the municipalities of Cúcuta, Los Patios and Villa del Rosario Resurgence of chikungunya Cutaneous manifestations of chikungunya during a recent epidemic in Clicut, north Kerala, south India Cutaneous manifestations of chikungunya fever Unusual facial melanosis in viral fever Immunoglobulin therapy in a patient with severe chikungunya fever and vesiculobullous lesions Chikungunya associated with cutaneous ulcerations Cutaneous manifestations of chikungunya during a recent epidemic in Clicut, north Kerala, south India Singal A, Pandhi D. Isolated Nail Pigmentation Associated with Chikungunya: A Hitherto Unreported Manifestation Tropism of the Chikungunya Virus Chikungunya Fever Presenting as Life Threatening Thrombotic Thrombocytopenic Purpura on behalf of the European Zika surveillance Network . Surveillance of Zika virus infection in the EU/EEA Sexual transmission of Zika virus and other flaviviruses: A living systematic review Zika Virus and Sexual Transmission: A New Route of Transmission for Mosquito-borne Flaviviruses Implication of sexual transmission of Zika on dengue and Zika outbreaks Investigating the sexual transmission of Zika virus Cutaneous manifestations of the Zika virus Cutaneous Manifestations of Zika Cutaneous Manifestations of Zika in Peru Cutaneous features of Zika virus infection: a clinicopathological overview Cutaneous manifestations of filovirus infections The next epidemic--lessons from Ebola The Ebola outbreak, 2013-2016: old lessons for new epidemics Case fatality rate for Ebola virus disease in west Africa Fruit bats as reservoirs of Ebola virus Cutaneous manifestations of the Ebola virus Ebola haemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observations in 103 patients Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg Viruses A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics